Introduction
Epidemiological studies have reported the association of diabetes mellitus (DM) and coronary artery disease (CAD). 1, 2 These evidences have led to the concept of DM as a coronary risk equivalent, requiring aggressive preventive, and therapeutic measures. 3 Moreover, patients with DM have been generally considered at a higher risk of silent myocardial ischaemia, supporting the possible prognostic benefit of ischaemia testing in asymptomatic diabetic patients. 4, 5 However, recent appraisals have changed these concepts,
showing that patients with DM have a substantially lower risk of future cardiac events than expected and questioning the real value of screening strategies in asymptomatic DM patients. 6, 7 Myocardial perfusion scintigraphy (MPS) on single-photon-emission computed tomography (SPECT) is used frequently in patients with DM to identify the presence of significant CAD. 4 One common finding in patients with DM is that the extent and severity of perfusion abnormalities may not reflect the effective CAD burden 8 and result in the frequent occurrence of 'false-positive' findings, possibly due to the presence of underlying microvascular dysfunction. 9, 10 An interaction between the specific stress-protocol adopted (i.e. exercise vs. vasodilator) and MPS accuracy has been also suggested, being exercise stress-MPS possibly characterized by a lower specificity than in normal patients. 11 Despite some preliminary studies, an accurate evaluation of MPS diagnostic power in detecting obstructive CAD in a consistent population of patients with DM has not been performed and the impact of the specific stress-protocol adopted on MPS diagnostic power in patients with and without DM is still lacking.
Accordingly, we aimed to evaluate the comparative accuracy of MPS performed on a dedicated cadmium-zinc-telluride (CZT) camera in patients with and without DM and to explore the impact of cardiac stress-protocol on MPS diagnostic power.
Materials and methods

Patient population
Between 2010 and 2016, 6120 subjects with anginal chest pain and suspected were referred to our institution for a scintigraphic evaluation of myocardial perfusion at rest and after stress with a CZT camera. Among those, 216 consecutive patients with DM, also submitted to invasive coronary angiography (ICA), were enrolled. Those patients with an ascertained diagnosis of DM according to current guidelines, 12 were referred to MPS mainly by the local community hospitals. From the same population of patients, a control group of subjects without DM, known coronary anatomy, and similar baseline clinical characteristics (particularly regarding age, sex, and chest pain characteristics) were also selected. In the control population, the absence of DM was documented according to the presence of a normal fasting plasma glucose in the absence of any antidiabetic drugs. In order to ensure an effective comparison of the two populations, DM and control patients were selected with a 1:2 ratio and also matched for CZT stress protocol (exercise vs. pharmacological). In the entire population, both patients with DM and controls were submitted to ICA within 3 months from the CZT study, as indicated by the referring physicians. Exclusion criteria were: previous acute coronary syndrome or coronary intervention, known CAD, haemodynamic instability, severely symptomatic heart failure, and previous cardiac infective/inflammatory disease. Moreover, to eliminate a possible bias in the analysis of the data, the four patients that underwent dobutamine MPS in the same study period were also excluded. The study was approved by the Local Ethical Committee and conformed to the Declaration of Helsinki on human research. Written informed consent was obtained from every patient.
Patient preparation and stress protocols
Patients discontinued beta-blockers, calcium-antagonists, and nitrates for 24 h before testing. Moreover, theophylline and caffeine containing products were also prohibited in the 24 h before MPS. Tc-tetrofosmin during stress and 296-370 MBq at rest). In all patients, stress and rest CZT imaging were acquired as previously described. 14, 15 Stress acquisitions were started 10 (exercise) to 15
(dipyridamole) min after the completion of the stress protocols, while rest scans were started 30 min after injection. Patients were imaged in the supine position with arms placed over their head without any detector or collimator motion. All images were acquired with a 32 Â 32 matrix and a 20% energy window centred at the 140 keV photopeak of 99m Tc. List mode files were acquired and stored. Images were reconstructed on a standard workstation (Xeleris II; GE Healthcare, Haifa, Israel) using a dedicated iterative algorithm.
14 All studies were reconstructed using a standard iterative algorithm with ordered-subset expectation maximization with 50 iterations, without resolution recovery or attenuation correction. A Butterworth post-processing filter (frequency 0.37, order 7) was applied to the reconstructed slices. The tomographic studies were also re-projected into 60 planar projections to emulate a standard SPECT layout.
Semiquantitative analysis of perfusion images
Stress and rest images were semiquantitatively scored according to the 17-segment left ventricular (LV) model and a five-point scale (0: normal, 1: equivocal, 2: moderate, 3: severe reduction in radioisotope uptake, and 4: absence of detectable tracer uptake). 15, 16 Accordingly, the summed stress score (SSS), summed rest score, and summed difference score (SDS) were calculated. Two experienced nuclear cardiologists performed the semiquantitative analysis independently and consensus was reached when necessary. A SDS >3 was identified as a measure of significant myocardial ischaemia. 17 Moreover, in each patient, the regional perfusion scores of the three coronary territories [left-anterior descending (LAD), left circumflex artery (LCX), and right coronary artery (RCA)] were also determined by adding the defect scores (DS) of the pertinent myocardial segments and reported as follows: DS-LAD, DS-LCX, and DS-RCA.
Analysis of gated images
LV function analysis was performed from 16-frames reformatted images using the commercially available software (Corridor4DM, Invia, Ann Arbor, MI, USA). End-diastolic volume (EDV), end-systolic volume, ejection fraction, and peak filling rate (EDV*s -1
) were automatically calculated. 18, 19 All functional measurements were obtained from rest and
Tc-tetrofosmin images. 
ICA
Coronary angiograms were quantified with a dedicated computer software (Advanced Vessel Analysis, Innova 3DXR for Advanced Workstations; GE Healthcare) using an automatic edge-contour detection algorithm to compute stenosis severity. Coronary stenosis >70% were considered obstructive, while luminal narrowings < _70% were recorded as non-obstructive.
Statistical analysis
Continuous variables were expressed as mean ± 1 SD and categorical variables as percentages. Groups were compared for categorical data using Fisher's exact test and for continuous variables using analysis of variance followed by Fisher's protected least significant difference for multiple comparisons. All tests were two-sided; a P-value of <0.05 was considered to be significant. The accuracy of MPS in unmasking the presence of significant coronary stenoses was assessed by the receiving operating characteristic analysis. Accordingly, the pertinent areas under the curves (AUC) with the appropriate 95% confidence intervals (CIs) were determined. The predictors of a reduced diagnostic specificity ('true-negative rate') on MPS were assessed at multivariate logistic regression analysis and the odds ratios (ORs) with the pertinent 95% CI determined. Statistical analyses were performed using JMP statistical software (SAS Institute Inc., 
Results
Characterization of the study population
The characteristics of the study population are summarized in Table 1 . Patients with DM had a significantly higher cardiovascular risk profile than controls, with a higher prevalence of hypertension (P = 0.006) and obesity (P = 0.049).
Interactions between DM, coronary anatomy, and myocardial perfusion: per-patient analysis
Patients with DM and controls showed a similar prevalence and extent of obstructive CAD ( Table 2) . Similarly, no differences regarding major LV functional parameters (i.e. left ventricular ejection fraction and cavitary volumes) were observed between the two patients categories. On the other hand, despite a comparable scar burden, patients with DM showed a higher extent of myocardial ischaemia than controls (P = 0.028). This finding was explained by the presence of more extensive ischaemia in diabetic patients with obstructive CAD than in controls ( Figure 1A) , and was limited to subjects submitted to vasodilator stress test ( Figure 1B) .
Interactions between DM, coronary anatomy, and myocardial perfusion: per-vessel analysis
Of the 1944 total vessels, 232 (12%) and 624 (32%) showed obstructive and non-obstructive CAD, respectively. While patients with DM and controls had the same proportion of obstructive coronary lesions (32% vs. 32%, P = NS), the former showed a higher prevalence of non-obstructive CAD (14% in DM vs. 10% in controls, P = 0.04). The interaction between DM, CAD severity, and myocardial ischaemic burden was then evaluated. Despite regional myocardial ischaemic burden gradually increased in normal, non-obstructive, and obstructive CAD, patients with DM showed significantly more Figure 1 Impact of the presence of CAD on myocardial ischaemic burden in patients with and without DM both in the whole study population (A) and in patients submitted to the specific cardiac stress-protocol (exercise vs. vasodilator) (B). severe ischaemia downstream obstructive coronary lesions than controls ( Figure 2A) . However, this finding was limited to patients submitted to vasodilator stress test, while disappeared in those undergoing exercise stress ( Figure 2B ).
MPS accuracy in patients with and without DM: the role of stress-protocol
In the overall population, MPS showed a significant accuracy in unmasking the presence of obstructive CAD (AUC 0.78, 95% CI 0.74-0.81; P < 0.001), which was maintained in patients with and without DM ( Figure 3A) . However, a significant interaction between stress-protocol and MPS accuracy was revealed. In fact, in patients with DM exercise stress MPS had a significantly lower diagnostic power than vasodilator stress SPECT (P for difference <0.001), because of a lower specificity (45% vs. 69%), while in the control group the accuracy of MPS was similar regardless of the stressprotocol adopted ( Figure 3B) . The relationship between patients characteristics, stress variables and MPS accuracy in patients submitted to exercise stress test was explored. Specifically, patients with DM attained a significantly lower %Watt max (76 ± 27% vs. 82 ± 26%, P = 0.038) than controls, despite similar values of %HR and of the other major exercise variables. In this respect, a significant correlation between %Watt max and body mass index (BMI) values was revealed (R = -0.41; P < 0.001). After correction for major clinical, LV functional and other exercise variables, a lower %Watt max (OR 0.98, 95% CI 0.97-0.99; P = 0.026) turned to be an independent predictor of a reduced diagnostic specificity on MPS.
Representative CZT and angiographic images of patients with and without DM are further reported (see Supplementary data online, Figures S1-S4) , outlining the better diagnostic accuracy of MPS in the non-diabetic cohort.
Discussion
This study shows that in patients with DM submitted to MPS the choice of the appropriate stress-modality is mandatory for the correct evaluation of the extent and severity of myocardial ischaemic burden. While our results confirm the generally elevated accuracy of MPS in detecting significant CAD, they also show the presence of a significantly lower specificity in patients with DM than controls when an exercise stress test is adopted.
DM and MPS accuracy: more than just CAD
Solid evidence shows that patients with DM are at high-risk for different cardiovascular disorders. 1, 3 Moreover, a significant association between the presence of DM and silent myocardial ischaemia has been suggested. 8, 20 In this respect, it has been also reported that diabetic patients may show an excess of inducible myocardial ischaemia Figure 2 Impact of CAD severity on the extent of regional myocardial ischaemia in patients with and without DM both in the whole study population (A) and in patients submitted to the specific cardiac stress-protocol (exercise vs. vasodilator) (B). Accordingly, while in the general population MPS is still among the most frequently performed stress cardiac imaging techniques, it may theoretically have some disadvantages in the evaluation of patients with DM. 11 In particular, the presence of diffuse myocardial blood flow impairment due to coronary endothelial/microvascular dysfunction might decrease the accuracy of MPS in unmasking the presence of focal coronary luminal narrowings. 9, 10 On the other hand, the presence of diffuse coronary atherosclerosis, as frequently observed in patients with long-standing DM, 8 might pose the conditions for a balanced reduction of myocardial perfusion, further decreasing the diagnostic power of MPS. Despite those theoretical drawbacks, the impact of DM on the diagnostic accuracy of MPS has been loosely investigated. 11 This results show that MPS maintains a similarly elevated accuracy in unmasking the presence of obstructive CAD both in patients with and without DM. Interestingly, no significant difference in terms of prevalence of obstructive CAD was revealed between patients with DM and controls. On the other hand, patients with DM also showed the presence a significantly higher prevalence of by-standing nonobstructive coronary lesions, which were in turn associated with some degrees of downstream myocardial ischaemia.
Regarding MPS evaluation, patients with DM were characterized by a higher myocardial ischaemic burden than controls. Nevertheless, in those patients myocardial ischaemia was mainly concentrated downstream obstructive coronary lesions, pointing against the presence of a diffuse impairment of myocardial perfusion. Finally, the lower diagnostic specificity of exercise stress SPECT in patients with DM than in control subjects has been already reported in a smaller cohort of patients, 11 possibly indicating a higher prevalence of false-positive imaging findings in this cohort of subjects. In fact, the lower cardiac workload that was obtained in those with DM, coupled with a significantly higher BMI may suggest a possibly higher prevalence of image artefacts in these patients. Further, dedicated studies will be needed to better describe these correlations.
Interaction between MPS accuracy and stress test protocol: the case of DM MPS is one of the most versatile cardiac imaging techniques that are available in clinical practice. However, despite the theoretical variety of possible stress protocols that can be performed, exercise stress still represents the cornerstone of cardiac functional evaluation. 22 On the other hand, in patients that cannot exercise sufficiently, a pharmacological stress test is generally performed, typically by means of a coronary vasodilator (i.e. adenosine or dipyridamole). In this respect, while in the general population the diagnostic accuracy of MPS seems generally unaffected by the specific stress-protocol that is adopted, 19 the prognostic value of the two main stress strategies appears somehow different.
23 Figure 3 Diagnostic accuracy of MPS in detecting obstructive CAD in patients with and without DM both in the whole study population (A) and in patients submitted to the specific cardiac stress-protocol (exercise vs. vasodilator) (B).
Moreover, it has been already reported that in some categories of patients, such as those with atrial fibrillation, an interaction between cardiac stress-protocol, and MPS accuracy can be present, particularly when exercise stress test is performed. 24 Accordingly, while the data of this study, confirm that the excellent accuracy of MPS is maintained in patients with and without DM, they also show that in the former patients the diagnostic power of MPS can be significantly influenced by the particular stress-protocol that is adopted. In particular, in patients with DM exercise stress MPS had a lower diagnostic efficiency in detecting obstructive CAD than vasodilator-stress, because of a relatively impaired specificity.
This finding could be explained by the fact that patients with DM submitted to exercise stress test were able to reach a significantly lower cardiac workload than controls, which ultimately resulted an independent predictor of impaired diagnostic specificity on MPS. Interestingly, while exercise stress MPS has been shown to riskstratify accurately patients with DM, 23, 25 it has been also demonstrated that diabetic patients with a reduced exercise capacity are characterized by a significantly impaired prognosis. 26, 27 In this respect, our data show that in those patients the accuracy of MPS could be reduced, possibly leading to the misdiagnosis of CAD. Present and previous data confirm that, in patients submitted to MPS, the choice of the stress-protocol (i.e. exercise vs. vasodilator) should be also based on the presence of simple constitutional and exercise-related variables (i.e. obesity and exercise capacity). Accordingly, our data suggest that in patients with DM that have obtained an insufficient cardiac workload on exercise stress test the results of MPS might be inaccurate.
Limitations
The retrospective nature of the study should be acknowledged. Since patients were referred to clinically indicated ICA also according to MPS results, some sort of referral bias cannot be completely ruledout. In these cases, the comparison of the normalcy rates of MPS in patients with low-likelihood of CAD has been proposed as a possible option to reduce the impact of referral bias. 11 However, in our population, only two patients presented a low pre-test likelihood of CAD (<15%), prohibiting this kind of analysis. In this respect, the fact that the outmost majority of the study patients had an intermediate-tohigh pre-test probability of CAD, further stresses the high level of appropriateness of patients selection. In this study, only a single anatomic cut-off value for the definition of significant CAD was used, namely >70% luminal narrowing. In this respect, since the relationship between CAD anatomic severity and myocardial ischaemic burden may be rather elusive, the use of a functional cut-off of CAD haemodynamic significance [i.e. using fraction flow reserve (FFR) in case of intermediate coronary stenosis] would have helped to better classify the patients studies and offered the chance to allow a more appropriate definition of CZT accuracy. 28 However, since in this study FFR was not used systematically, its implementation in the diagnostic algorithm was impossible. Accordingly, in order to try to try to be more specific, a relatively more stringent cut-off value of CAD anatomic severity was used (70% rather than the classical 50% diemeter reduction threshold) 29 reasonably reducing the occurrence of falsepositive angiographic findings. The fact that a subgroup of patients was injected despite a theoretically submaximal (%HR <85%) exercise stress test might have limited MPS accuracy. 14 However, considering that the proportion of those patients was similar in patients with DM and controls and that the majority of those had presented electrocardiographic or clinical signs of ischaemia during stress protocol, the impact of this variable should be considered limited. Accordingly, despite similar values of %HR, in control patients MPS accuracy after an exercise stress test remained high, while in those with DM the diagnostic value of exercise-MPS was reduced. The use of dipyridamole rather than the relatively more potent adenosine might have theoretically reduced the accuracy of MPS in detecting significant CAD. However, since several studies have reported an elevated accuracy of dipyridamole myocardial perfusion imaging in unmasking the presence of CAD, 14, 30 the impact of the chosen coronary stressor should be considered limited. While patients were matched for pre-test probability of CAD, those with DM presented a significantly higher cardiovascular risk profile (i.e. a higher prevalence of major cardiovascular risk factors), possibly impacting the diagnostic accuracy of MPS because of a higher prevalence of underlying microvascular dysfunction. However, since in this study, myocardial perfusion abnormalities were concentrated downstream vessels with CAD ( Figure 2) , the impact of microvascular dysfunction on MPS accuracy should be considered minor. While dobutamine MPS is also performed in our laboratory when both exercise and vasodilator stress test is not feasible, those patients were not included in the analyses because of their limited numerosity (four subjects). Regarding patients selection, while the presence of DM was ascertained according to current guidelines, 12 its absence was solely base on fasting plasma glucose levels in the absence of any antidiabetic drugs. Accordingly, while the presence of some patients with early stages of DM in the control group cannot be completely excluded, a different screening strategy (i.e. with the use of glucose tolerance test) should be considered unrealistic.
Conclusions
MPS was accurate in detecting obstructive CAD both in patients with and without DM. However, in the former patients a significant interaction between MPS accuracy and the specific stress protocol was observed, with a lower diagnostic power of exercise stress MPS than vasodilator-stress one. This finding could be explained by the fact that patients with DM attained a significantly lower exercise-related cardiac workload than controls, possibly due to a higher prevalence of obesity, resulting in a lower diagnostic specificity in unmasking the presence of obstructive CAD.
